Title |
Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
|
---|---|
Published in |
Molecular Cell, July 2010
|
DOI | 10.1016/j.molcel.2010.06.026 |
Pubmed ID | |
Authors |
Adele Adamo, Spencer J. Collis, Carrie A. Adelman, Nicola Silva, Zuzana Horejsi, Jordan D. Ward, Enrique Martinez-Perez, Simon J. Boulton, Adriana La Volpe |
Abstract |
Fanconi anemia (FA) is a complex cancer susceptibility disorder associated with DNA repair defects and infertility, yet the precise function of the FA proteins in genome maintenance remains unclear. Here we report that C. elegans FANCD2 (fcd-2) is dispensable for normal meiotic recombination but is required in crossover defective mutants to prevent illegitimate repair of meiotic breaks by nonhomologous end joining (NHEJ). In mitotic cells, we show that DNA repair defects of C. elegans fcd-2 mutants and FA-deficient human cells are significantly suppressed by eliminating NHEJ. Moreover, NHEJ factors are inappropriately recruited to sites of replication stress in the absence of FANCD2. Our findings are consistent with the interpretation that FA results from the promiscuous action of NHEJ during DNA repair. We propose that a critical function of the FA pathway is to channel lesions into accurate, as opposed to error-prone, repair pathways. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 2% |
United States | 3 | 1% |
Italy | 1 | <1% |
Vietnam | 1 | <1% |
Chile | 1 | <1% |
India | 1 | <1% |
Switzerland | 1 | <1% |
Denmark | 1 | <1% |
Australia | 1 | <1% |
Other | 0 | 0% |
Unknown | 247 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 73 | 28% |
Researcher | 64 | 25% |
Student > Master | 22 | 8% |
Student > Bachelor | 18 | 7% |
Professor | 15 | 6% |
Other | 39 | 15% |
Unknown | 30 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 129 | 49% |
Biochemistry, Genetics and Molecular Biology | 79 | 30% |
Medicine and Dentistry | 10 | 4% |
Chemistry | 4 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | <1% |
Other | 7 | 3% |
Unknown | 30 | 11% |